Literature DB >> 1572047

In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis.

M Kodama1, Y Matsumoto, M Fujiwara.   

Abstract

BACKGROUND: To elucidate the mechanisms of immune-related myocardial injuries, we examined whether autoimmune myocarditis was passively transferable by use of humoral or cellular factors. METHODS AND
RESULTS: Active myocarditis was elicited in Lewis rats by immunization with human cardiac myosin fraction in complete Freund's adjuvant. This experimental myocarditis was characterized by macroscopic features such as pericardial effusion, enlargement of the heart, and gray discoloration of the cardiac surface. Histologically, extensive myocardial necrosis and numerous inflammatory cell infiltrations were observed. Interestingly, multinucleated giant cells were frequently observed in the lesions. Transfer of the disease by the humoral factor was examined by use of fresh sera and immunoglobulin fraction of pooled sera from rats with severe myocarditis, and transfer by the cellular factor was tested by use of spleen cells and lymph node cells from the diseased rats. When naive Lewis rats were given 15.75 mg of immunoglobulin fraction, no particular change was observed in the hearts. Fresh sera also could not elicit myocarditis in recipient rats. In contrast, intravenous injection of spleen cells or lymph node cells that were cultured for 3 days in the presence of 1 microgram/ml of concanavalin A elicited severe myocarditis. The macroscopic and microscopic findings of passively transferred myocarditis are essentially the same as those found in actively induced myocarditis. Multinucleated giant cells were also observed in the lesions of transferred myocarditis.
CONCLUSIONS: This study demonstrates direct evidence for in vivo lymphocyte-mediated myocardial injuries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572047     DOI: 10.1161/01.cir.85.5.1918

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Authors:  Shouxin Zhang; Xiaoyan Liu; Chengming Sun; Jun Yang; Lihong Wang; Jie Liu; Lei Gong; Yanyan Jing
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

2.  Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Authors:  K Fuse; M Kodama; H Hanawa; Y Okura; M Ito; T Shiono; S Maruyama; S Hirono; K Kato; K Watanabe; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 3.  Recognition and optimum management of myocarditis.

Authors:  A L Caforio; W J McKenna
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

4.  FR167653 suppresses the progression of experimental autoimmune myocarditis.

Authors:  Seitaro Maruyama; Kiminori Kato; Makoto Kodama; Yuji Okura; Satoru Hirono; Koichi Fuse; Haruo Hanawa; Osamu Nakagawa; Mikio Nakazawa; Takashi Miida; Eisin Yaoita; Tadashi Yamamoto; Ikuo Inoue; Yoshifusa Aizawa
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

5.  Cardiac myosin-Th17 responses promote heart failure in human myocarditis.

Authors:  Jennifer M Myers; Leslie T Cooper; David C Kem; Stavros Stavrakis; Stanley D Kosanke; Ethan M Shevach; DeLisa Fairweather; Julie A Stoner; Carol J Cox; Madeleine W Cunningham
Journal:  JCI Insight       Date:  2016-06-16

Review 6.  Cardiac contractile proteins and autoimmune myocarditis.

Authors:  T Izumi; H Hanawa; M Saeki; M Kodama
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

7.  Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.

Authors:  S Koyama; M Kodama; T Izumi; A Shibata
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

8.  Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis.

Authors:  M Kodama; S Zhang; H Hanawa; A Shibata
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats.

Authors:  Pablo Nakagawa; Yunhe Liu; Tang-Dong Liao; Xiaojuan Chen; Germán E González; Kevin R Bobbitt; Derek Smolarek; Ed L Peterson; Ross Kedl; Xiao-Ping Yang; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-24       Impact factor: 4.733

Review 10.  Dilated cardiomyopathy update: infectious-immune theory revisited.

Authors:  Chuichi Kawai; Akira Matsumori
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.